All Low-Concentration Atropine for Myopia Progression Articles
-
1.2KResearch ReviewResearch Highlights from Day One of ARVO 2025
The Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting is being held in Salt Lake City, Utah, from May...
-
811ImplementationSetting Up a Corporate Myopia Clinic: A Step-by-Step Guide
May 1, 2025 By Sherman Tung, OD, FAAO, FIAOMC, IACMM Throughout my career, I have had the privilege of practicing in various...
-
1.5KResearch ReviewCan We Differentiate Between ‘Responders’ and ‘Non-Responders’ to Myopia Control Interventions?
September 16, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In their article “Can we really distinguish ‘responders’ from ‘non-responders’ to...
-
1.7KResearch ReviewPotentially Delaying the Onset of Myopia in Children
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Low concentration (0.01% to 0.05%) atropine effectively slows myopia progression in...
-
6.7KPharmaceutical InterventionsLow-Concentration Atropine for Myopia Progression (LAMP)
A summary of the LAMP Study results